Cover Image
市場調查報告書

北美大麻市場估計、預測 2015-2022年:對用途、衍生物、地區的關注

North America Cannabis Market - Focus on Application, Derivative and Region: Estimation & Forecast 2015-2020

出版商 BIS Research 商品編碼 338587
出版日期 內容資訊 英文 249 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
北美大麻市場估計、預測 2015-2022年:對用途、衍生物、地區的關注 North America Cannabis Market - Focus on Application, Derivative and Region: Estimation & Forecast 2015-2020
出版日期: 2015年09月01日 內容資訊: 英文 249 Pages
簡介

加州的大麻市場,產生美國全州最大的11億5,000萬美元的收益,另一方面,預計奧勒岡州、羅德島州各以36.10%,36.93%的年複合成長率急速成長。

本報告提供北美的大麻市場相關調查、市場概要、發展趨勢、法規法律體制、大麻、工業用大麻市場、各國需求預測,及主要企業簡介等系統性資訊。

第1章 調查手法、範圍、對照

第2章 摘要整理

第3章 北美的大麻市場簡介

  • 大麻市場發展、趨勢
  • 北美大麻生態系統:估計、預測
  • 美國大麻市場樂觀的估計
  • 美國大麻市場稅收估計

第4章 北美的大麻市場上的主要策略、發展

  • 簡介
  • M&A
  • 聯盟、合作,及合資企業
  • 產品銷售
  • 產業擴大
  • 產品檢驗
  • 其他

第5章 市場動態

  • 簡介
  • 市場成長的促進要素
  • 市場課題

第6章 北美的大麻產業分析

  • 波特的五力分析
  • 價值鏈分析

第7章 法規 & 法律體制,國際集團及遵守

  • 簡介
  • 法規團體
  • 法律體制
  • 遵守
  • 國際集團

第8章 市場規模:估計、分析及預測,各衍生物

  • 簡介
    • 市場統計
    • 大麻/花
    • 工業用大麻
    • 其他濃縮物/產品

第9章 市場規模:估計、分析及預測,各用途

  • 簡介
  • 大麻的用途
    • 醫療用途
    • 大麻的娛樂用途
  • 工業用大麻的用途
    • 食品、嬰兒用品
    • 服裝類、紡織品
    • 其他大麻產品

第10章 市場規模分析 & 預測:市場需求

  • 簡介
  • 美國
    • 市場統計
    • 加州
    • 科羅拉多州
    • 華盛頓州
    • 亞利桑那州
    • 密西根州
    • 奧勒岡州
    • 其他
    • 法律、法律規範
    • 主要企業
  • 加拿大
    • 市場統計
    • 主要企業

第11章 主要企業簡介

  • 栽培業者
  • 生產業者
  • 醫藥品 & 研究企業
  • IT
  • 設備 & 基礎設施
  • 投資顧問業、教育
  • 其他
  • 應用企業

圖表

目錄
Product Code: VE01

Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp.

The following pointers will encompass the scope of the research study and will lend a better understanding to the reader.

  • The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp
  • The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized
  • Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014)
  • The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others
  • Through the forecast period, the 'other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana
  • The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity
  • The report includes the estimates of different entities of the cannabis ecosystem
  • The report also includes the optimistic revenue estimate for the benchmark year only for the U.S
  • Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included

The size of the market for cannabis implies that market participants are more varied. Thus, the company profile section has been broken down into different types of market participants: producers, information technology, funding & finance, equipment & infrastructure, research & development, advisory services & education, branding, sales & marketing, and retail & dispensary.

EXECUTIVE SUMMARY

Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applications and wide acceptance. Owing to the medicinal and industrial uses of the cannabis plant, cannabis market is growing rapidly. Factors like multi-faceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others.

The U.S. state California generates the maximum revenue $1.15 billion in the marijuana market among all the states in the U.S. while Oregon and Rhode Island will be growing at the fastest CAGR of 36.10% and 36.93% respectively. If the industry keeps on growing with the same pace, it will spread to all the 50 states of the U.S.

Table of Contents

1 RESEARCH METHODOLOLOGY, SCOPE AND COVERAGE

  • 1.1 SCOPE OF THE STUDY
  • 1.2 RESEARCH METHODOLOGY
    • 1.2.1 OVERALL MARKET ESTIMATION AND FORECAST
    • 1.2.2 BIS RESEARCH METHODOLOGY
  • 1.3 REPORT DESCRIPTION

2 EXECUTIVE SUMMARY

3 INTRODUCTION TO NORTH AMERICAN CANNABIS MARKET

  • 3.1 CANNABIS MARKET EVOLUTION AND TREND
  • 3.2 THE CANNABIS ECOSYSTEM IN NORTH AMERICA: ESTIMATE AND FORECAST
  • 3.3 THE OPTIMISTIC ESTIMATE FOR THE U.S. MRIJUANA MARKET
  • 3.4 TAX REVENUE ESTIMATION FOR THE U.S. MARIJUANA MARKET

4 KEY STRATEGIES AND DEVELOPMENT IN THE NORTH AMERICAN CANNABIS MARKET (2013-2015)

  • 4.1 INTRODUCTION
  • 4.2 MERGERS AND ACQUISITIONS
  • 4.3 PARTNERSHIP, COLLABORATION & JOINT VENTURES
  • 4.4 PRODUCT LAUNCH
  • 4.5 BUSINESS EXPANSION
  • 4.6 PRODUCT TESTING
  • 4.7 OTHERS

5 MARKET DYNAMICS

  • 5.1 INTRODUCTION
  • 5.2 MARKET DRIVERS
    • 5.2.1 AUTOMATION TRANSFORMING THE CANNABIS INDUSTRY
      • 5.2.1.1 Collaboration of the Vending and Cannabis industry
      • 5.2.1.2 Automated Irrigation Systems and Fertigation
    • 5.2.2 INCREASING ADOPTION OF INFORMATION TECHNOLOGY IN THE CANNABIS INDUSTRY
    • 5.2.3 RAPID ADOPTION OF CANNABIS FOR MEDICAL PURPOSES
    • 5.2.4 MULTI-FACETED APPLICATIONS OF CANNABIS DERIVATIVES
    • 5.2.5 THE PROFITABLE INTEGRATION OF THE HYDROPONICS AND CANNABIS INDUSTRY
    • 5.2.6 THE COMBINED EFFECT OF VAPER'S PREFERENCE FOR CANNABIS OIL AND INCREASING ADOPTION OF E-CIGARETTE
  • 5.3 MARKET CHALLENGES
    • 5.3.1 HIGHLY VOLATILE REGULATORY FRAMEWORK
    • 5.3.2 ABSENCE OF MARKET LEADERS AND STANDARDS
    • 5.3.3 THE ISSUES OF PERCEPTION (REPUTATION OF MARIJUANA)/MARIJUANA STIGMA
    • 5.3.4 FEDERAL LEVEL CHALLENGES
      • 5.3.4.1 Lack of availability of bank loans to set up operations due to federal banking prerequisites
      • 5.3.4.2 Federal ban on growing industrial hemp forcing the market players to import raw hemp
    • 5.3.5 HIGHLY FRAGMENTED SUPPLY CHAIN
    • 5.3.6 ENVIRONMENTAL HAZARDS

6 NORTH AMERICA CANNABIS INDUSTRY ANALYSIS

  • 6.1 PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1 THREAT OF NEW ENTRANTS
      • 6.1.1.1 Entry Barriers (Government Policy and Capital Requirements)
      • 6.1.1.2 Access to distribution channels
      • 6.1.1.3 Economies of Scale
      • 6.1.1.4 Product Differentiation
    • 6.1.2 BARGAINING POWER OF BUYERS
      • 6.1.2.1 Concentration of Buyers
      • 6.1.2.2 Importance of Volume to Buyers
      • 6.1.2.3 Threat of Backward Integration
      • 6.1.2.4 Buyer's Information about Supplier's Product
      • 6.1.2.5 The existence of Black Market
      • 6.1.2.6 Switching Cost
      • 6.1.2.7 Legal and Regulatory Framework
      • 6.1.2.8 Presence of Substitutes
    • 6.1.3 BARGAINING POWER OF SUPPLIERS
      • 6.1.3.1 Supplier Concentration
      • 6.1.3.2 Threat of forward integration
      • 6.1.3.3 Product Differentiation
      • 6.1.3.4 Switching Cost
    • 6.1.4 THREAT FROM SUBSTITUTES
      • 6.1.4.1 Buyer's Propensity towards Substitute
      • 6.1.4.2 Consumer's Switching Cost
    • 6.1.5 INTENSITY OF COMPETITIVE RIVALRY
      • 6.1.5.1 Customer's Loyalty Towards Brand
      • 6.1.5.2 Intermittent Over Capacity
      • 6.1.5.3 Product Differentiation
      • 6.1.5.4 Industry Concentration
      • 6.1.5.5 Entry Barriers
      • 6.1.5.6 Exit barriers
  • 6.2 VALUE CHAIN ANALYSIS
    • 6.2.1 INTRODUCTION
    • 6.2.2 CANNABIS GROWERS/PRODUCERS
    • 6.2.3 PHARMACEUTICAL COMPANIES
      • 6.2.3.1 Research Facilities
    • 6.2.4 PROCESSING INDUSTRIES
    • 6.2.5 PACKAGING INDUSTRIES
    • 6.2.6 DISPENSARIES
      • 6.2.6.1 Retail
      • 6.2.6.2 Medical
      • 6.2.6.3 Retail Outlets

7 REGULATORY & LEGAL FRAMEWORK, CONSORTIUMS AND COMPLIANCES

  • 7.1 INTRODUCTION
  • 7.2 REGULATORY BODIES
    • 7.2.1 HEALTH CANADA- MARIJUANA FOR MEDICAL PURPOSES REGULATIONS (MMPR)
    • 7.2.2 COUNCIL ON RESPONSIBLE CANNABIS REGULATION (CRCR)
    • 7.2.3 NATIONAL ORGANIZATION FOR THE REFORM OF MARIJUANA LAWS (NORML)
  • 7.3 LEGAL FRAMEWORK
    • 7.3.1 FEDERAL MARIJUANA LAW- CONTROLLED SUBSTANCE ACT (CSA)
    • 7.3.2 MARIJUANA CONTROL ACT 2014
    • 7.3.3 HEMP FARMING ACT 2015
  • 7.4 COMPLIANCES
    • 7.4.1 MASSACHUSETTS MARIJUANA COMPLIANCE
    • 7.4.2 MARIJUANA ENFORCEMENT TRACKING REPORTING COMPLIANCE (METRC)
  • 7.5 CONSORTIUMS
    • 7.5.1 AMERICAN HERBAL PRODUCTS ASSOCIATION (AHPA)
    • 7.5.2 ASSOCIATION OF RESPONSIBLE CANNABIS PUBLIC COMPANIES (ARCPC)
    • 7.5.3 HEMP INDUSTRIES ASSOCIATION (HIA)
    • 7.5.4 DRUG POLICY ALLIANCE
    • 7.5.5 INTERNATIONAL ASSOCIATION FOR CANNABINOID MEDICINE (IACM)
    • 7.5.6 NATIONAL CANNABIS INDUSTRY ASSOCIATION (NCIA)
    • 7.5.7 CANADIAN MEDICAL CANNABIS INDUSTRY ASSOCIATION (CMCIA)
    • 7.5.8 CALIFORNIA CANNABIS INDUSTRY ASSOCIATION (CCIA)
    • 7.5.9 ILLINOIS CANNABIS INDUSTRY ASSOCIATION
    • 7.5.10 NORTH AMERICAN INDUSTRIAL HEMP COUNCIL INC. (NAIHC)
    • 7.5.11 CANADIAN HEMP TRADE ALLIANCE (CHTA)
    • 7.5.12 KENTUCKY HEMP INDUSTRIES ASSOCIATION(KYHIA)

8 MARKET SIZING - ESTIMATION, ANALYSIS & FORECAST BY DERIVATIVE

  • 8.1 INTRODUCTION
    • 8.1.1 MARKET STATISTICS
    • 8.1.2 MARIJUANA/FLOWERS
      • 8.1.2.1 Market statistics
      • 8.1.2.2 Key Players
    • 8.1.3 INDUSTRIAL HEMP
      • 8.1.3.1 Market statistics
      • 8.1.3.2 Key Players
    • 8.1.4 OTHER CONCENTRATES/PRODUCTS
      • 8.1.4.1 Kief
      • 8.1.4.2 Hash
      • 8.1.4.3 Hash Oil
      • 8.1.4.4 Tinctures
      • 8.1.4.5 Infusions

9 MARKET SIZING- ESTIMATION, ANALYSIS & FORECAST BY APPLICATION

  • 9.1 INTRODUCTION
    • 9.1.1 MARKET STATISTICS
  • 9.2 APPLICATIONS OF MARIJUANA
    • 9.2.1 MEDICINAL APPLICATIONS
      • 9.2.1.1 Market Statistics
      • 9.2.1.2 Key Players
    • 9.2.2 RECREATIONAL APPLICATION OF MARIJUANA
      • 9.2.2.1 Market Statistics
  • 9.3 APPLICATIONS OF INDUSTRIAL HEMP
    • 9.3.1 FOOD AND BABY CARE
      • 9.3.1.1 Market statistics
    • 9.3.2 CLOTHING & TEXTILE
      • 9.3.2.1 Market Statistics
    • 9.3.3 OTHER HEMP PRODUCTS
      • 9.3.3.1 Market Statistics

10 MARKET SIZING ANALYSIS & FORECAST, BY MARKET DEMAND

  • 10.1 INTRODUCTION
    • 10.1.1 MARKET STATISTICS
  • 10.2 THE U.S.
    • 10.2.1 MARKET STATISTICS
    • 10.2.2 CALIFORNIA
    • 10.2.3 COLORADO
    • 10.2.4 WASHINGTON
    • 10.2.5 ARIZONA
    • 10.2.6 MICHIGAN
    • 10.2.7 OREGON
    • 10.2.8 OTHERS
    • 10.2.9 LEGAL & REGULATORY FRAMEWORK
      • 10.2.9.1 MARIJUANA
      • 10.2.9.2 INDUSTRIAL HEMP
    • 10.2.10 KEY MARKET PLAYERS
  • 10.3 CANADA
    • 10.3.1 MARKET STATISTICS
    • 10.3.2 KEY MARKET PLAYERS

11 KEY MARKET PLAYERS PROFILE

  • 11.1 GROWERS
    • 11.1.1 CANADIAN CANNABIS CORPORATION
      • 11.1.1.1 Company Overview
      • 11.1.1.2 Financials
        • 11.1.1.2.1 Overall Financials
        • 11.1.1.2.2 Financial Summary
      • 11.1.1.3 Key Developments
    • 11.1.2 PLANDAI BIOTECHNOLOGY
      • 11.1.2.1 Company Overview
      • 11.1.2.2 Financials
        • 11.1.2.2.1 Overall Financials
        • 11.1.2.2.2 Financial Summary
      • 11.1.2.3 Key Developments
    • 11.1.3 TWEED MARIJUANA INC.
      • 11.1.3.1 Company Overview
      • 11.1.3.2 Financials
        • 11.1.3.2.1 Overall Financials
        • 11.1.3.2.2 Financial Summary
      • 11.1.3.3 KEY DEVELOPMENTS
    • 11.1.4 AFFINOR GROWERS
      • 11.1.4.1 Company Overview
      • 11.1.4.2 FINANCIALS
        • 11.1.4.2.1 Overall Financials
        • 11.1.4.2.2 Financial Summary
      • 11.1.4.3 Key Developments
  • 11.2 PRODUCERS
    • 11.2.1 CANNABIS SATIVA INC.
      • 11.2.1.1 Company Overview
      • 11.2.1.2 Financials
        • 11.2.1.2.1 Overall Financials
        • 11.2.1.2.2 Financial Summary
      • 11.2.1.3 Key Developments
    • 11.2.2 CANNAVEST
      • 11.2.2.1 Company Overview
      • 11.2.2.2 Financials
        • 11.2.2.2.1 Overall Financials
        • 11.2.2.2.2 Financial summary
      • 11.2.2.3 Key Developments
    • 11.2.3 CANNA BRANDS INC.
      • 11.2.3.1 Company Overview
      • 11.2.3.2 Financial summary
      • 11.2.3.3 Key Developments
    • 11.2.4 OMNICANNA HEALTH SOLUTIONS
      • 11.2.4.1 Company Overview
      • 11.2.4.2 Financial Summary
      • 11.2.4.3 Key Developments
    • 11.2.5 PRIVATEER HOLDINGS, INC.
      • 11.2.5.1 Company Overview
      • 11.2.5.2 Key Developments
  • 11.3 PHARMACEUTICAL & RESEARCH COMPANIES
    • 11.3.1 ARENA PHARMACEUTICALS, INC.
      • 11.3.1.1 Company Overview
      • 11.3.1.2 Financials
        • 11.3.1.2.1 Overall Financials
        • 11.3.1.2.2 Financial Summary
      • 11.3.1.3 Key Developments
    • 11.3.2 CANNABICS PHARMACEUTICALS INC.
      • 11.3.2.1 Company Overview
      • 11.3.2.2 Financial Summary
      • 11.3.2.3 Key Developments
    • 11.3.3 CANNABIS SCIENCE, INC.
      • 11.3.3.1 Company Overview
      • 11.3.3.2 Financials
        • 11.3.3.2.1 Overall Financials
        • 11.3.3.2.2 Financial Summary
      • 11.3.3.3 Key Developments
    • 11.3.4 GW PHARMACEUTICALS
      • 11.3.4.1 Company Overview
      • 11.3.4.2 Financials
        • 11.3.4.2.1 Overall Financials
        • 11.3.4.2.2 Revenue By Segment
        • 11.3.4.2.3 Revenue by Region
        • 11.3.4.2.4 Financial Summary
      • 11.3.4.3 Key Developments
    • 11.3.5 HEMP, INC.
      • 11.3.5.1 Company Overview
      • 11.3.5.2 Financials
        • 11.3.5.2.1 Overall Financials
        • 11.3.5.2.2 Financial Summary
      • 11.3.5.3 Key Developments
    • 11.3.6 INSYS THERAPEUTICS
      • 11.3.6.1 Company Overview
      • 11.3.6.2 Financials
        • 11.3.6.2.1 Overall Financials
        • 11.3.6.2.2 Revenue BY Segment
        • 11.3.6.2.3 Financial Summary
      • 11.3.6.3 Key Developments
    • 11.3.7 MEDICAL MARIJUANA INC.
      • 11.3.7.1 Company Overview
      • 11.3.7.2 Financials
        • 11.3.7.2.1 Overall Financials
        • 11.3.7.2.2 Financial Summary
      • 11.3.7.3 Key Developments
    • 11.3.8 22ND CENTURY GROUP, INC.
      • 11.3.8.1 Company Overview
      • 11.3.8.2 FINANCIALS
        • 11.3.8.2.1 Overall Financials
        • 11.3.8.2.2 Financial Summary
      • 11.3.8.3 Key Developments
    • 11.3.9 OTSUKA PHARMACEUTICAL CO. LTD
      • 11.3.9.1 Company Overview
      • 11.3.9.2 Financials
        • 11.3.9.2.1 Overall Financials
        • 11.3.9.2.2 Revenue by Segment
        • 11.3.9.2.3 Revenue by Region
        • 11.3.9.2.4 Financial Summary
      • 11.3.9.3 KEY DEVELOPMENTS
      • 11.3.10 SANOFI PHARMACEUTICALS
      • 11.3.10.1 Company Overview
      • 11.3.10.2 Financials
        • 11.3.10.2.1 Overall Financials
        • 11.3.10.2.2 Financial Summary
  • 11.4 INFORMATION TECHNOLOGY
    • 11.4.1 AGRISOFT DEVELOPMENT GROUP
      • 11.4.1.1 Company overview
      • 11.4.1.2 Key Developments
    • 11.4.2 ENDEXX CORPORATION
      • 11.4.2.1 Company Overview
      • 11.4.2.2 Financials
        • 11.4.2.2.1 Overall Financials
      • 11.4.2.3 Key Developments
    • 11.4.3 GREEN TECHNOLOGY SOLUTIONS INC. (GTSO)
      • 11.4.3.1 Company Overview
      • 11.4.3.2 Financials
        • 11.4.3.2.1 Overall Financials
        • 11.4.3.2.2 Financial Summary
      • 11.4.3.3 Key Developments
    • 11.4.4 QUANTUM 9
      • 11.4.4.1 Company Overview
      • 11.4.4.2 Financials
      • 11.4.4.3 Key Developments
  • 11.5 EQUIPMENT & INFRASTRUCTURE
    • 11.5.1 ADVANCED CANNABIS SOLUTIONS
      • 11.5.1.1 Company Overview
      • 11.5.1.2 Financials
        • 11.5.1.2.1 Overall Financials
        • 11.5.1.2.2 Revenue by Segment
        • 11.5.1.2.3 Financial Summary
      • 11.5.1.3 Key Developments
    • 11.5.2 MEDBOX, INC.
      • 11.5.2.1 Company Overview
      • 11.5.2.2 Financials
        • 11.5.2.2.1 Overall Financials
        • 11.5.2.2.2 Financial Summary
      • 11.5.2.3 Key Developments
    • 11.5.3 SURNA, INC.
      • 11.5.3.1 Company Overview
      • 11.5.3.2 Financials
        • 11.5.3.2.1 Overall Financials
        • 11.5.3.2.2 Financial Summary
      • 11.5.3.3 Key Developments
  • 11.6 ADVISORY SERVICES AND EDUCATION
    • 11.6.1 CANNA GROW HOLDINGS
      • 11.6.1.1 Company Overview
      • 11.6.1.2 Financials
        • 11.6.1.2.1 Overall Financials
        • 11.6.1.2.2 financial Summary
      • 11.6.1.3 Key Development
  • 11.7 OTHERS
    • 11.7.1 ABATTIS BIOCEUTICALS CORPORATION
      • 11.7.1.1 Company Overview
      • 11.7.1.2 Financials
        • 11.7.1.2.1 Overall Financials
        • 11.7.1.2.2 Financial summary
      • 11.7.1.3 Key Developments
    • 11.7.2 CANNABIS THERAPY CORPORATION
      • 11.7.2.1 Company Overview
      • 11.7.2.2 Financials
        • 11.7.2.2.1 Overall Financials
        • 11.7.2.2.2 Financial summary
      • 11.7.2.3 Key Developments
    • 11.7.3 CANNACARE DOCS
      • 11.7.3.1 Company Overview
  • 11.8 APPLICATION (APPS) COMPANIES
    • 11.8.1 MASS ROOTS
      • 11.8.1.1 Company Overview
    • 11.8.2 EAZE
      • 11.8.2.1 Company Overview
      • 11.8.2.2 Key Developments
    • 11.8.3 WEEDMAPS
      • 11.8.3.1 Company Overview
    • 11.8.4 MEADOW
      • 11.8.4.1 Company Overview
      • 11.8.4.2 Key Developments
    • 11.8.5 NESTDROP
      • 11.8.5.1 Company Overview
      • 11.8.5.2 Key Developments
    • 11.8.6 LEAFLY
      • 11.8.6.1 Company Overview
    • 11.8.7 GRASSP
      • 11.8.7.1 Company Overview
    • 11.8.8 DAVE
      • 11.8.8.1 Company Overview
    • 11.8.9 FRWEED PRO
      • 11.8.9.1 Company Overview

LIST OF TABLES

  • TABLE 1 TIMELINE OF MEDICAL MARIJUANA LEGALIZATION
  • TABLE 2 THE CANNABIS ECOSYSTEM IN NORTH AMERICA REVENUE SPLIT ($BILLION), 2015-2020
  • TABLE 3 FULL LEGALIZATION OF MARIJUANA ACROSS THE U.S. AND ASSOCIATED TAX REVENUE ESTIMATE
  • TABLE 4 COMPARISON OF GROWING MARIJUANA IN SOIL-BASED AND SOIL-LESS MEDIUM
  • TABLE 5 CANNABIS SATIVA VS CANNABIS INDICA
  • TABLE 6 NORTH AMERICA CANNABIS DERIVATIVE MARKET VALUE ($MILLION), 2015-2020
  • TABLE 7 NORTH AMERICA MARIJUANA MARKET VALUE($MILLION), BY APPLICATION, 2015-2020
  • TABLE 8 NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
  • TABLE 9 NORTH AMERICA MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 10 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
  • TABLE 11 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($MILLION), BY DISTRIBUTIONMODE, 2015-2020
  • TABLE 12 NORTH AMERICA INDUSTRIAL HEMP MARKET VALUE ($ MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 13 NORTH AMERICA CANNABIS APPLICATION MARKET VALUE ($MILLION), 2015-2020
  • TABLE 14 DISEASES & CURE BY CANNABIS
  • TABLE 15 INFORMATION ABOUT KEY MEDICINAL MARIJUANA DRUGS IN NORTH AMERICA
  • TABLE 16 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY DISTRIBUTION MODE, 2015-2020
  • TABLE 17 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 18 NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 19 NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 20 NORTH AMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 21 NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATION MARKET VALUE ($MILLION), BY GEOGRAPHY, 2015-2020
  • TABLE 22 NORTH AMERICA CANNABIS MARKET BY REGION ($ MILLION), 2015-2020
  • TABLE 23 THE U.S CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
  • TABLE 24 THE U.S. CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020
  • TABLE 25 THE U.S. MARIJUANA MARKET VALUE ($MILLION), BY KEY STATES, 2015-2020
  • TABLE 26 MARIJUANA LEGALIZATION DETAILS BY STATES
  • TABLE 27 MARIJUANA POSESSION DETAILS
  • TABLE 28 INDUSTRIAL HEMP POSESSION DETAILS
  • TABLE 29 CANADA CANNABIS MARKET VALUE ($MILLION), BY DERIVATIVE, 2015-2020
  • TABLE 30 CANADA CANNABIS MARKET VALUE ($MILLION), BY APPLICATION, 2015-2020

LIST OF FIGURES

  • FIGURE 1 BIS RESEARCH METHODOLOGY
  • FIGURE 2 THE EUROPE E-LIQUID MARKET-RESEARCH METHODOLOGY
  • FIGURE 3 CANNABIS COMPARISON BY DERIVATIVE ($MILLION) 2015-2020
  • FIGURE 4 CANNABIS COMPARISON BY APPLICATION ($ MILLION) 2014-2020
  • FIGURE 5 CANNABIS COMPARISON BY GEOGRAPHY ($ MILLION) 2014-2020
  • FIGURE 6 THE CANNABIS ECOSYSTEM WITH KEY PLAYERS
  • FIGURE 7 AN OPTIMISTIC ESTIMATE FOR U.S. MARIJUANA MARKET (2014)
  • FIGURE 8 KEY MERGERS & ACQUISITIONS (2013-15)
  • FIGURE 9 KEY PARTNERSHIPS & COLLABORATIONS (2013-15)
  • FIGURE 10 KEY PRODUCT LAUNCHES (2013-15)
  • FIGURE 11 KEY BUSINESS EXPANSION ACTIVITIES (2013-15)
  • FIGURE 12 KEY PRODUCT TESTING ACTIVITIES (2013-15)
  • FIGURE 13 OTHER KEY DEVELOPMENTS (2013-15)
  • FIGURE 14 BENEFITS OF USING CANNABIS VENDING MACHINES
  • FIGURE 15 WHY CANNABIS INDUSTRY NEEDS STANDARDS
  • FIGURE 16 NORTH AMERICA CANNABIS INDUSTRY ANALYSIS-PORTER'S FIVE FORCES
  • FIGURE 17 NORTH AMERICA CANNABIS MARKET VALUE CHAIN ANALYSIS
  • FIGURE 18 FEATURE OF MMPR
  • FIGURE 19 MISSION OF CRCR
  • FIGURE 20 MISSION OF NORML
  • FIGURE 21 PROPOSED BEST PRACTICES FOR REGULATION OF CANNABIS GROWING BY AHPA
  • FIGURE 22 ARCPC MISSION
  • FIGURE 23 HIA MISSION
  • FIGURE 24 DPA MISSION
  • FIGURE 25 STEPS TAKEN BY IACM IN THE CANNABIS INDUSTRY
  • FIGURE 26 KEY FEATURES OF NCIA
  • FIGURE 27 CMCIA MISSION
  • FIGURE 28 NAIHC MISSION
  • FIGURE 29 KEY VARIETIES OF CANNABIS STRAINS
  • FIGURE 30 THE PSYCHOACTIVE EFFECTS OF MARIJUANA
  • FIGURE 31 MEDICAL BENEFITS OF MARIJUANA
  • FIGURE 32 INDUSTRIES BENEFITING FROM INDUSTRIAL HEMP
  • FIGURE 33 APPLICATIONS OF CANNABIS PLANT
  • FIGURE 34 NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
  • FIGURE 35 NORTH AMERICA RECREATIONAL MARIJUANA MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
  • FIGURE 36 APPLICATIONS OF INDUSTRIAL HEMP
  • FIGURE 37 NORTH AMERICA INDUSTRIAL HEMP FOOD AND BABY CARE PRODUCTS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
  • FIGURE 38 NORTHAMERICA INDUSTRIAL HEMP CLOTHING AND TEXTILES MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
  • FIGURE 39 NORTH AMERICA INDUSTRIAL HEMP OTHER APPLICATIONS MARKET VALUE ($MILLION) VS Y-O-Y, 2015-2020
  • FIGURE 40 LEGALIZATION STATUS OF CANNABIS
  • FIGURE 41 CANADIAN CANNABIS CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
  • FIGURE 42 PLANDAI BIOTECH OVERALL FINANCIALS, 2012-15 ($ MILLION)
  • FIGURE 43 TWEED MARIJUANA OVERALL FINANCIALS, 2013-15 ($ MILLION)
  • FIGURE 44 AFFINOR GROWERS OVERALL FINANCIALS, 2012-14 ($ MILLION)
  • FIGURE 45 CANNABIS SATIVA OVERALL FINANCIALS, 2012-14 ($ MILLION)
  • FIGURE 46 CANNAVEST OVERALL FINANCIALS, 2012-14 ($ MILLION)
  • FIGURE 47 ARENA PHARMACEUTICALS OVERALL FINANCIALS, 2012-14 ($MILLION)
  • FIGURE 48 CANNABIS SCIENCE, INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
  • FIGURE 49 GW PHARMACEUTICALS; OVERALL FINANCIALS 2012-14 ($MILLION)
  • FIGURE 50 REVENUE BY SEGMENT 2012-14
  • FIGURE 51 REVENUE BY REGION2012-2014
  • FIGURE 52 HEMP INC. OVERALL FINANCIALS, 2012-15 ($ MILLION)
  • FIGURE 53 INSYS THERAPEUTICS OVERALL FINANCIALS, 2012-14 ($ MILLION)
  • FIGURE 54 MEDICAL MARIJUANA INC. OVERALL FINANCIALS, 2012-14 ($MILLION)
  • FIGURE 55 22ND CENTURY GROUP OVERALL FINANCIALS, 2012-14 ($ MILLION)
  • FIGURE 56 OTSUKA OVERALL FINANCIALS, 2012-2014 ($ MILLION)
  • FIGURE 57 SANOFIPHARMA OVERALL FINANCIALS, 2012-14 ($ MILLION)
  • FIGURE 58 ENDEXX CORPORATION OVERALL FINANCIALS, 2012-2014 ($MILLION)
  • FIGURE 59 GREEN TECHNOLOGY SOLUTIONS; OVERALL FINANCIALS, 2012-2015 ($ MILLION)
  • FIGURE 60 ADVANCED CANNABIS SOLUTIONS OVERALL FINANCIALS, 2013-2014 ($ MILLION)
  • FIGURE 61 MEDBOX OVERALL FINANCIALS, 2012-2014 ($ MILLION)
  • FIGURE 62 SURNA INC. OVERALL FINANCIALS, 2012-2014 ($MILLION)
  • FIGURE 63 CANNAGROW OVERALL FINANCIALS, 2012-14 ($MILLION)
  • FIGURE 64 ABATTIS BIOCEUTICALS OVERALL FINANCIALS 2013-14 ($MILLION)
  • FIGURE 65 CANNABIS THERAPY CORP. OVERALL FINANCIALS, 2014-15 ($MILLION)
Back to Top